Second malignant neoplasms in children and adolescents in Moscow Region

Cover Page

Cite item

Full Text

Abstract

Second malignant neoplasms are the most devastating consequences of anticancer therapy. We have studied the frequency of second malignant neoplasms among children and adolescents in Moscow Region. 10 cases were observed during the years 2000—2008. Longterm survival can be archived in some patients using multimodal treatment.

About the authors

D. Yu. Kachanov

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Regional Oncological hospital

Author for correspondence.
Email: totti111@list.ru

Moscow; Balashiha

Russian Federation

R. T. Abdullaev

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Regional Oncological hospital

Moscow; Balashiha

Russian Federation

N. V. Kruchko

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology

Moscow

Russian Federation

T. V. Shamanskaya

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology

Moscow

Russian Federation

E. V. Inyushkina

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Regional Oncological hospital

Moscow; Balashiha

Russian Federation

K. V. Dobrenkov

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology

Moscow

Russian Federation

S. R. Varfolomeeva

Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology; Moscow Regional Oncological hospital

Moscow; Balashiha

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.